Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ihor W. Rak"'
Autor:
Herbert Y. Meltzer, Lisa A Arvanitis, Vincent T Ciuryla, Anastasia M. Wilson, Anthony F. Lehman, Jelle W Kylstra, Walter W Hong, Ihor W Rak, William T. Carpenter
Publikováno v:
Schizophrenia Research. 32:51-58
Treating schizophrenia is expensive. Preventing rehospitalization of patients with schizophrenia provides an attractive opportunity for cost savings, especially for patients with 'revolving-door' or multiple-episode schizophrenia. Reducing the occurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2c24e5b1e946ad44fdffde17b194398
https://doi.org/10.1016/s0920-9964(98)00040-1
https://doi.org/10.1016/s0920-9964(98)00040-1
Autor:
Ihor W. Rak
Publikováno v:
American Journal of EEG Technology. 35:162-166
The last decade has seen the development and testing of several new drugs to control previously drug-resistant seizure disorders. This brief review introduces technologists to felbamate, gabapentin, and lamotrigine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f42c20d81c8f9734afd74f94447efaf4
https://doi.org/10.1080/00029238.1995.11080515
https://doi.org/10.1080/00029238.1995.11080515
Autor:
Lisa A Arvanitis, Ihor W Rak
Publikováno v:
Schizophrenia Research. 24:196-197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66c14c9b8e9ffd28a3c44172b125f941
https://doi.org/10.1016/s0920-9964(97)82563-7
https://doi.org/10.1016/s0920-9964(97)82563-7
Autor:
Lisa A Arvanitis, Ihor W Rak
Publikováno v:
Schizophrenia Research. 24:199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d77362f80530a654d404e7bc5a9e1a5
https://doi.org/10.1016/s0920-9964(97)82570-4
https://doi.org/10.1016/s0920-9964(97)82570-4
Autor:
Ihor W Rak, Lisa A Aevanitis
Publikováno v:
Schizophrenia Research. 24:196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39eb258a5e0bb3cef05e65b4fc5671d1
https://doi.org/10.1016/s0920-9964(97)82562-5
https://doi.org/10.1016/s0920-9964(97)82562-5
Publikováno v:
Pediatrics. 78:438-443
During a 40-month period, in 24 of 643 (4%) newly diagnosed patients with systemic cancer younger than 18 years of age (range: 3 months to 17 years) spinal cord disease developed. Patients with spinal cord disease included 21 children with metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23a7eaae480a321e221e743c1068f780
https://doi.org/10.1542/peds.78.3.438
https://doi.org/10.1542/peds.78.3.438
Publikováno v:
JAMA: Journal of the American Medical Association; 4/23/2003-4/30/2003, Vol. 289 Issue 16, p2120, 8p, 1 Chart
Publikováno v:
Journal of Clinical Neurophysiology; Jan1998, Vol. 15 Issue 1, p78-87, 10p
Autor:
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rebecca A. English, Neil Weisfeld
There is growing recognition that the United States'clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there
